-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Diabetes mellitus is a systemic metabolic disease characterized by hyperglycemia
Diabetes is a systemic metabolic disease characterized by hyperglycemia
METHODS: A mouse model of DOP was established
Results: The DOP mouse model was successfully established
Conclusion: LncRNA-AK137033 inhibits the osteogenic potential of DOP-ASCs by regulating the level of DNA methylation in the sFrp2 promoter region and regulating the Wnt signaling pathway
LncRNA-AK137033 inhibits the osteogenic potential of DOP-ASCs by regulating the DNA methylation level in the sFrp2 promoter region and regulating the Wnt signaling pathway
LncRNA-AK137033 inhibits the osteogenic potential of adipose-derived stem cells in diabetic osteoporosis by regulating Wnt signaling pathway via DNA methylation.
Leave a comment here